Science
Covid-19 has sparked an unprecedented mobilization of researchers looking to create a drug that can stem the spread of the virus. Globally, drug developers are working on as many as 100 experimental vaccines. But as nations rush to ease lockdowns and restart economies, some countries seem to want to secure early supplies of a vaccine for themselves. James Paton reported on efforts to democratize international access to vaccines, and the dangers of creating immunization gaps.
See omnystudio.com/listener for privacy information.
More Episodes
Can Drugstores Save Us?
2021-01-22
2021-01-22
The Global Vaccine Gap
2021-01-20
2021-01-20
Where to Be in a Pandemic (Rebroadcast)
2021-01-18
2021-01-18
Can We Fix the Chaotic Vaccine Rollout?
2021-01-15
2021-01-15
Why Healthcare Workers Refuse the Vaccine
2021-01-13
2021-01-13
What Allergic Vaccine Reactions Mean For You
2021-01-11
2021-01-11
The U.K. Health System Threatens to Buckle
2021-01-08
2021-01-08
Vaccines via Eventbrite
2021-01-06
2021-01-06
How It All Started (Rebroadcast)
2021-01-01
2021-01-01
What We Know About Covid's Origins
2020-12-30
2020-12-30
A New Technology Hiding in Covid Vaccines
2020-12-23
2020-12-23
Lessons From Past Vaccines
2020-12-21
2020-12-21
Voices From the U.S. Vaccine Program
2020-12-16
2020-12-16
Louisiana's Vaccine Test Run
2020-12-14
2020-12-14
Who Should Get the First Doses?
2020-12-09
2020-12-09
A Turning Point Week Ahead
2020-12-07
2020-12-07
The Struggle to Distribute the Vaccine
2020-12-04
2020-12-04
Get this podcast on your
phone, FREE
